HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Greg M Arndt Selected Research

SE486-11

1/2021A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Greg M Arndt Research Topics

Disease

14Neoplasms (Cancer)
01/2022 - 04/2006
5Neuroblastoma
09/2021 - 02/2015
3Leukemia
01/2022 - 12/2014
3Colorectal Neoplasms (Colorectal Cancer)
02/2015 - 01/2009
2Breast Neoplasms (Breast Cancer)
09/2021 - 04/2006
2Neoplasm Metastasis (Metastasis)
08/2016 - 04/2006
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Diffuse Intrinsic Pontine Glioma
03/2021
1Rheumatoid Arthritis
01/2021
1Carcinogenesis
01/2021
1Melanoma (Melanoma, Malignant)
08/2016
1Diabetic Retinopathy (Retinopathy, Diabetic)
06/2009
1Necrosis
01/2009
1Asthma (Bronchial Asthma)
04/2004

Drug/Important Bio-Agent (IBA)

4Histone Deacetylase InhibitorsIBA
01/2022 - 03/2020
3Drug CombinationsIBA
01/2022 - 08/2016
3Biological ProductsIBA
09/2021 - 01/2014
2Pharmaceutical PreparationsIBA
01/2022 - 10/2021
2Histone Deacetylases (Histone Deacetylase)IBA
01/2022 - 01/2021
2RNA (Ribonucleic Acid)IBA
06/2009 - 01/2009
1PanobinostatIBA
01/2022
1CBLC137IBA
01/2022
1ChromatinIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1VorinostatFDA Link
09/2021
1GoldIBA
03/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2021
1SE486-11IBA
01/2021
1Auranofin (Ridaura)FDA Link
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2021
1PolyubiquitinIBA
01/2021
1Ubiquitin-Specific ProteasesIBA
01/2021
1VemurafenibIBA
08/2016
1HydrazinesIBA
07/2016
1quinolineIBA
07/2016
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2016
1Proteins (Proteins, Gene)FDA Link
02/2015
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2014
1MicroRNAs (MicroRNA)IBA
10/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2009
1Fluorouracil (Carac)FDA LinkGeneric
01/2009
1Glycoproteins (Glycoprotein)IBA
04/2006
1Fibronectins (Fibronectin)IBA
04/2006
1Small Interfering RNA (siRNA)IBA
04/2006
1Metalloproteases (Metalloproteinases)IBA
04/2006
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
04/2006
1Caspase 3 (Caspase-3)IBA
04/2006
1Immunoglobulins (Immunoglobulin)IBA
04/2006
1Phosphotransferases (Kinase)IBA
04/2006
1OX40 LigandIBA
04/2004

Therapy/Procedure

6Therapeutics
01/2022 - 04/2006
1Drug Therapy (Chemotherapy)
01/2022
1Heterologous Transplantation (Xenotransplantation)
01/2022
1Precision Medicine
01/2022